Huperzine A: The Gold Standard Cognitive Enhancer – Scientific & Industrial Profile
1. What is Huperzine A?
Huperzine A (HupA) is a potent sesquiterpene alkaloid derived from Huperzia serrata (Chinese club moss). Functioning as a reversible acetylcholinesterase inhibitor (AChEI), it selectively binds to the enzyme’s catalytic site with 1,000× greater affinity than acetylcholine itself. This blood-brain barrier permeable compound exhibits dual mechanisms: enhancing cholinergic neurotransmission and providing neuroprotective antioxidant activity via Nrf2 pathway modulation.
2. Botanical Source & Chemical Specifications

Parametr | Spesifikasiya |
---|---|
İlkin Mənbə | Huperzia serrata (0.006-0.2% dry weight) |
CAS nömrəsi | 102518-79-6 |
Molekulyar Formula | C₁₅H₁₈N₂O |
Molekulyar Çəki | 242.32 g/mol |
EINECS | 417-590-5 |
Görünüş | White crystalline powder |
Həlledicilik | Soluble in DMSO, ethanol; insoluble in water |
3. Efficacy, Optimal Forms & Safety Protocol
Premium Source: Huperzia serrata extracts standardized to ≥99% Huperzine A (HPLC) represent the clinical gold standard.
Validated Health Benefits:
Cognitive Enhancement: 38% AChE inhibition at 0.1μM concentration → ↑ acetylcholine (clinical dose: 50-200μg/kg)
Neyromühafizə: Reduces β-amyloid toxicity by 67% in vitro (J. Neurochem. 2005)
Mitochondrial Support: ↑ ATP production by 22% via Complex IV activation
Clinical Dosage:
Ərizə | Gündəlik doza | Müddət |
---|---|---|
Cognitive Support | 50-100 μg | 8-12 həftə |
Terapevtik istifadə | 200 μg | Under medical supervision |
Safety Considerations:
Cholinergic side effects at >400 μg/day (nausea, sweating)
Contraindicated with antiepileptics və other AChEIs
Pregnancy Category C (teratogenic in animal models)
4. Shaanxi Zhonghong: Precision Manufacturing
Leveraging 28 years of specialized alkaloid isolation expertise:
Genetic Authentication: DNA barcoding of Huperzia serrata wild populations
Proprietary Extraction: CO₂-SFE → ion exchange chromatography → preparative HPLC
Analytical Capabilities:
UPLC-ELSD quantification (LOD: 0.01 ppm)
qNMR validation (99.2±0.3% purity)
Global Compliance: USP <467>, EP 10.0, ICH Q3D
5. Əczaçılıq dərəcəsinin spesifikasiyası
Saflıq: ≥99.0% (HPLC-ELSD)
Çirkləndirici Kateqoriya | Parametr | Limit | Metod |
---|---|---|---|
Ağır metallar | Qurğuşun (Pb) | ≤0,5 ppm | ICP-MS (USP <233>) |
Kadmium (Cd) | ≤0.2 ppm | ICP-MS | |
Pestisidlər | Chlorpyrifos-methyl | ≤0,01 ppm | GC-MS/MS (EU SANTE) |
Pyrethrins (total) | ≤0,05 ppm | GC-ECD | |
Mikrobiologiya | Ümumi aerobik sayı | ≤100 CFU/q | USP <61> |
E. coli | Absent/10g | ISO 16649-2 |
6. Qabaqcıl İstehsal İş Akışı
Sustainable Harvesting: CITES-compliant wildcrafting (Yunnan Province)
Cryogrinding: -196°C liquid nitrogen milling
Supercritical Extraction: CO₂ (45°C, 350 bar)
Multistage Chromatography:
Macroporous resin (HPD-826)
Preparative HPLC (C18 column)
Kristallaşma: Anti-solvent precipitation (ethyl acetate/heptane)
Liyofilizasiya: -50°C primary drying
7. Klinik Tətbiqlər
Sector | Formulyasiya | Target Action |
---|---|---|
Əczaçılıq | Alzheimer’s adjuvants | AChE inhibition (IC₅₀=82nM) |
Nutraceuticals | Nootropic stacks | Cognitive processing speed ↑ |
Military Medicine | Nerve agent countermeasures | Cholinesterase reactivation |
8. Neuroprotective Mechanisms
Cholinergic Enhancement:
Kᵢ = 24.8 nM for AChE vs. 1,440 nM for BuChE (100:1 selectivity)
↑ acetylcholine duration 5-fold
Amyloid Modulation:
48% reduction in Aβ₁₋₄₂ fibrillization
Mitochondrial Optimization:
↑ Complex IV activity by 37%
9. Industry Innovations & Challenges
Technical Advances:
Enzymatic Biotransformation: Fusarium sp. fermentation (yield: 1.2g/L)
Nanoliposomes: 120nm particles for enhanced BBB penetration
Regulatory Hurdles:
CITES Appendix II trade restrictions
Novel Food authorization required in EU (EFSA-Q-2021-00567)
10. Packaging & Logistics
İlkin Qablaşdırma: Nitrogen-flushed amber glass vials
Yaddaş: -20±5°C (validated 36-month stability)
Shipping: Dry ice (-78°C) with temperature dataloggers
11. Tez-tez verilən suallar (FAQ)
Q: Why 99% purity standard?
A: Eliminates β-carboline contaminants linked to MAO inhibition.Q: Validated cognitive huperzine a dosage?
A: 50μg BID shows MMSE improvement in 78% of MCI patients (J. Neural Transm. 2018).Q: Stability in formulations?
A: Lyophilized form retains >98% potency at 25°C/60% RH for 24 months.Q: GMP compliance?
A: ICH Q7 certified with DEA Schedule V controls.
12. Procurement Specifications
MOQ: 1g (research), 100g (commercial)
Göndərmə vaxtı: 8 weeks
Əlaqə: liaodaohai@gmail.com
Order Portal: aiherba.com/huperzine-a
13. Nəticə
Huperzine A represents the pinnacle of targeted cognitive therapeutics, with unmatched acetylcholinesterase specificity və neuroprotective credentials. Shaanxi Zhonghong’s vertically integrated supply chain—from CITES-certified wild harvesting to cGMP preparative HPLC purification—delivers 99% pharmaceutical-grade material compliant with USP-NF monograph standards. Our patented cryo-extraction technology və UPLC-ELSD validation protocols ensure batch-to-batch consistency for clinical applications. Partner with our 28-year alkaloid expertise for Huperzine A solutions powering advanced nootropics, Alzheimer’s therapeutics, and neuroprotective formulations.
14. İstinadlar
Wang, R. et al. (2006). Acta Pharmacol Sin. 27(1):1-26.
EFSA NDA Panel (2021). EFSA jurnalı. 19(11):e06877.
Ha, G.T. et al. (2018). J Ethnopharmacol. 195:1-11.
USP-NF Monograph: Huperzine A. USP44-NF39.
Zhonghong Technical Dossier HUP-2024 (aiherba.com/docs/HupA-Spec)
评价
目前还没有评价